Material and Support for our Retail and Distribution Partners(requires login)
This may result in reduced functionality and affect the graphical presentation of this site.However, all content will still be available.
We don’t like to think about them, but we know they’re there. Those pesky parasites living large on our pastures and paddocks and – eventually – making themselves at home inside our horses and working to ensure that another generation of parasites follows them. Parasites meet your match – the anthelmintic.
For years, deworming programs were geared to eradicating parasites from horses. This was not only counterproductive but also unrealistic. Today, the goals of deworming are three-fold:
Time moves on and we have evolved in our thinking, learning and understanding. Sometimes, what is old is new again and we revisit the very compounds that have dramatically changed the way intestinal parasites are managed in horses. Including exactly how they work in the horse to remove the target parasites. One such compound, fenbendazole, has been around for more than six decades, but has stood the test of time.
Going to battle at the cellular levelHow a dewormer works – known as mode of action – plays an important role in determining the efficacy and safety of the treatment. Fenbendazole goes to battle at the cellular level, destroying the threat before it can cause problems for your horse. Let’s explore how this is possible and why it is important.
Take an in-depth look at the unique mode of action that makes fenbendazole extremely safe and highly effective against the most significant parasite threats.
Inside the cells of animals and parasites are structures called microtubules, which are important in a number of cellular processes. When fenbendazole is absorbed by the worm, it interacts with the worm’s microtubules. Fenbendazole works by binding to the beta-tubulin within the microtubules and inhibiting their formation, resulting in disruption of cell division. This potent disruption blocks the parasite's ability to produce energy, starving the parasite until it dies.
What makes fenbendazole unique is that it is more attracted to parasite beta-tubulin than that of the animal being treated. This means the animal’s cells are not destroyed along with the parasite. This is also the reason the parasite is slowly killed, and why fenbendazole is a safe choice for deworming in so many different situations and for every horse, regardless of age, size or body condition. As well as safe for the environment and many other species.
Tackling two of the toughest parasite threatsAscarids are the primary parasite concern in foals and weanlings, while small strongyles are considered the primary parasite risk in adult horse populations. Fenbendazole’s unique mode of action is uniquely suited to treating both.
Ascarids (roundworms)Ascarids present a two-pronged threat. When eggs are ingested, the larvae hatch and migrate through the walls of the small intestine to the liver, and eventually invade the lungs, creating inflammation and ill thrift. Larvae in the lungs get coughed up, swallowed and passed into the intestinal tract where they become adults in the small intestine. Adult ascarids are large – up to 40 centimeters in length. Severe ascarid infestations can create intestinal obstruction that could lead to impaction colic or intestinal rupture, which can be fatal.
Fenbendazole stops the life cycle by targeting adult ascarids in the small intestine. Fenbendazole’s potent, but safe mode of action, starves the ascarid until it dies. This results in a slow kill, which decreases the likelihood of potential side effects (endotoxic shock, impactions), which may occur after deworming foals with heavy ascarid infections using other classes of dewormers.1,2 The slow kill method of fenbendazole is one of the reasons it’s the recommended option for ascarids. The second reason is because it remains highly effective. Ascarids are developing worldwide resistance to ivermectin, moxidectin and pyrantel pamoate.3,4,5,6
Encysted small strongylesSmall strongyles pose a significant threat because of their ability to encyst. When third stage small strongyle larvae are ingested, they pass through the stomach and go to the lower intestines, where they burrow in the wall of the intestine. At this time the larvae may stop maturing and simply hibernate – or encyst – for prolonged periods of time. As many as 90% of the larvae may become encysted in this manner and remain in this stage of development for 4 months or up to 3 years.7 Over time, encysted larvae continue to accumulate in the intestinal wall. When they start developing again at once – due to seasonal influences – and they all emerge at once (typically spring), this may cause severe problems for the horse, and even death.
The larvicidal dose of fenbendazole, Panacur® POWERPAC, is the only dewormer proven to treat all stages of encysted small strongyles, including the early third-stage that encyst.7 It can uniquely penetrate the mucosal wall and kill the encysted larvae in hiding before the threat of mass emergence.
Fenbendazole is not rapidly metabolized, which means effective concentrations are maintained for an extended period of time in the plasma and gut, which increases its effectiveness against immature and arrested larvae, such as encysted small strongyles. This is the basis for the Panacur® POWERPAC five-dose regimen.
Standing the test of timeTimes have changed along with our approach to deworming horses. Now more than ever, it is important to work with your veterinarian to implement deworming programs informed by science to ensure the anthelmintics we have may continue to stand the test of time. This means there is no one-size-fits-all deworming prescription. A better understanding of how anthelmintics such as fenbendazole work is one way you can equip yourself to make the best choices when it comes to deworming your horses.Fenbendazole’s mode of action makes it extremely safe and uniquely suited to two of the most common and significant parasites threatening horses. However, dewormers such as fenbendazole have the best chance of success when partnered with fecal monitoring and strategic use of non-chemical parasite control strategies.
Take a closer look at Panacur® and discuss its benefits with your veterinarian. Visit www.Science-of-Effective.com for more information.
Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
Do not use in horses intended for human consumption. When using Panacur® (fenbendazole) Paste 10% concomitantly with trichlorfon, refer to the manufacturer's labels for use and cautions for trichlorfon.
1 AAEP Parasite Control Guidelines. Revised February 2016.2 Cribb, NC, Cote, NM, Bouré, LP, Peregrine, AS. Acute small intestinal obstruction associated with Parascaris equorum infection in young horses: 25 cases (1985-2004). N Z Vet J. 2006 Dec;54(6):338-43.3 Craig TM, Diamond PL, Ferwerda NS, et al. Evidence of ivermectin resistance by Parascaris equorum on a Texas horse farm. J Eq Vet Sci 2007; 27:67-714 Hearn FP, Peregrine AS. Identification of foals infected with Parascaris equorum apparently resistant to ivermectin. J Am Vet Med Assoc. 2003; 223(4):482-485.5 Boersema JH, Eysker M, Nas JW. Apparent resistance of Parascaris equorum to macrocyclic-lactones. Vet Rec 2002; 150(9):279-2816 Schougaard H, Nielsen MK. Apparent ivermectin resistance of Parascaris equorum in foals in Denmark. Vet Rec 2007;160: 439-4407 PANACUR (fenbendazole) Paste 10% equine dewormer product label.
Copyright © 2018 Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co., Inc. All rights reserved.
Copyright © Intervet Inc., a subsidiary of Merck & Co., All Rights Reserved.Intervet Inc. d/b/a Merck Animal Health, Madison, NJ 07901